Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Oncology Biomarkers Market Revenue Growth On Track For A 14.3% CAGR Through 2030
The oncology biomarkers market has seen rapid expansion in recent years. This market is set to increase from $17.3 billion in 2025 to $19.73 billion by 2026, at a compound annual growth rate (CAGR) of 14.1%. Historically, this growth has been fueled by the expansion of cancer screening programs, breakthroughs in molecular biology research, enhanced availability of biomarker testing platforms, a rise in oncology clinical trials, and increased collaboration between research institutions and hospitals.
The oncology biomarkers market is projected for significant expansion over the coming years. By 2030, its valuation is anticipated to reach $33.63 billion, demonstrating a compound annual growth rate (CAGR) of 14.3%. This projected growth during the forecast period is fueled by several factors, including the increasing need for individualized oncology treatments, the expansion of AI-driven methods for biomarker discovery, greater investment in cancer genomics, wider acceptance of liquid biopsy techniques, and an elevated emphasis on early cancer detection and ongoing monitoring. Key developments anticipated during this period involve a greater embrace of precision oncology diagnostics, an increased utilization of genetic and protein biomarkers, the growing incorporation of bioinformatics into biomarker analysis, the ongoing expansion of companion diagnostics creation, and a heightened focus on tailored cancer therapy.
Get A Free Sample Report With In-Depth Market Insights:
Oncology Biomarkers Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of cancer is anticipated to stimulate the expansion of the oncology biomarker market in the future. Cancer is defined as a condition where certain body cells multiply without control and progressively disseminate to other parts of the body. Oncological biomarkers furnish additional details about the specific type of cancer by examining genes, proteins, and other compounds found in a person’s system. For example, in February 2024, the World Health Organization, an intergovernmental organization located in Switzerland, projected that by 2050, new cancer cases would exceed 35 million, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the escalating incidence of cancer is a key factor driving the growth of the oncology biomarkers market.
Oncology Biomarkers Market Segment Performance And Emerging Opportunities
The oncology biomarkers market covered in this report is segmented –
1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types
2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types
3) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
4) By End-User: Hospitals, Academic And Cancer Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers
2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)
3) By Other Biomarker Types: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers
Oncology Biomarkers Market Trends Powering Strategic Industry Growth
Leading companies in the oncology diagnostics market are focused on developing advanced biomarker-based assays. These are designed to improve early cancer detection, monitor minimal residual disease (MRD), and assess patient response to therapies. Minimal residual disease indicates the small amount of cancer cells that might remain in the body after treatment, which could lead to recurrence if not identified. For example, in May 2024, Tempus, a US-based artificial intelligence and precision medicine company, introduced its MRD test portfolio. This included the xM test and the xM (NeXT Personal Dx) test, which were developed by Personalis. The portfolio encompasses both tumor-naïve and tumor-informed assays, created to detect early cancer recurrence and residual disease, alongside monitoring patient responses to immunotherapy. By utilizing circulating tumor biomarkers, these assays offer clinicians sensitive and actionable insights to guide patient management.
Oncology Biomarkers Market Company Landscape And Competitive Strategy
Major companies operating in the oncology biomarkers market are F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Epigenomics AG, OncoDNA SA
View The Full Oncology Biomarkers Market Report:
Oncology Biomarkers Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the oncology biomarkers market in 2025. The regions covered in the oncology biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model